FDA Warning Letter — Bret R. Rutherford, M.D.

Case 670544 — FEI 3023259471

The FDA took a Warning Letter action against Bret R. Rutherford, M.D. on Mar 21, 2024 (New York, NY). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Bret R. Rutherford, M.D.
Date
Mar 21, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
New York, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.